Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  MUNDKUR CHRISTINE
 2. Date of Event Requiring Statement (Month/Day/Year)
03/28/2008		 3. Issuer Name and Ticker or Trading Symbol
BARR PHARMACEUTICALS INC [BRL]
(Last)
(First)
(Middle)
BARR PHARMACEUTICALS, INC., 225 SUMMIT AVENUE		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Executive Officer
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

MONTVALE, NJ 07645		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 28,875.715
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Incentive Stock Options   (1) 08/07/2012 Common Stock 11,278 $ 26.58 D  
Non-Qualified Stock Options   (2) 08/07/2012 Common Stock 42,720 $ 26.58 D  
Incentive Stock Options   (3) 07/30/2013 Common Stock 2,310 $ 43.34 D  
Non-Qualified Stock Options   (4) 07/30/2013 Common Stock 42,690 $ 43.34 D  
Incentive Stock Options 08/04/2007 08/04/2014 Common Stock 2,856 $ 35.01 D  
Non-Qualified Stock Options   (5) 08/04/2014 Common Stock 27,144 $ 35.01 D  
Incentive Stock Options with Tandem SARs 07/27/2008 07/27/2015 Common Stock 2,128 $ 46.99 D  
Stock Appreciation Rights   (6) 07/27/2015 Common Stock 27,872 $ 46.99 D  
Incentive Stock Options with Tandem SARs 07/26/2009 07/26/2016 Common Stock 2,049 $ 48.8 D  
Stock Appreciation Rights   (7) 07/26/2016 Common Stock 27,951 $ 48.8 D  
Incentive Stock Options with Tandem SARs 03/07/2010 03/07/2017 Common Stock 2,020 $ 49.49 D  
Stock Appreciation Rights   (8) 03/07/2017 Common Stock 12,980 $ 49.49 D  
Stock Appreciation Rights   (9) 08/09/2017 Common Stock 30,000 $ 55.81 D  
Incentive Stock Options with Tandem SARs 03/04/2011 03/04/2018 Common Stock 2,031 $ 49.22 D  
Stock Appreciation Rights   (10) 03/04/2018 Common Stock 72,969 $ 49.22 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
MUNDKUR CHRISTINE
BARR PHARMACEUTICALS, INC.
225 SUMMIT AVENUE
MONTVALE, NJ 07645		       Chief Executive Officer  

Signatures

S/S William T McKee as Attorney-in-Fact for Christine Mundkur 04/01/2008
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) 3,760 vested on 8/7/2003 3,759 vested on 8/7/2004 3,759 vested on 8/7/2005
(2) 14,240 vested on 8/7/2003 14,240 vested on 8/7/2004 14,240 vested on 8/7/2005
(3) 2 vested on 7/30/2004 1 vested on 7/30/2005 2,307 vested on 7/30/2006
(4) 14,999 vested on 7/30/2004 14,998 vested on 7/30/2005 12,693 vested on 7/30/2006
(5) 10,000 vested on 8/4/2005 10,000 vested on 8/4/2006 7,144 vested on 8/4/2007
(6) 10,000 vested on 7/27/2006 10,000 vested on 7/27/2007 7,872 on 7/27/2008
(7) 10,000 vested on 7/26/2007 10,000 on 7/26/2008 7,951 on 7/26/2009
(8) 5,000 vested on 3/7/2008 5,000 on 3/7/2009 2,980 on 3/7/2010
(9) 10,000 on 8/9/2008 10,000 on 8/9/2009 10,000 on 8/9/2010
(10) 25,000 on 3/4/2009 25,000 on 3/4/2010 22,969 on 3/4/2011

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.